Allergy/Asthma News

Zabalafin hydrogel clinically improved itch and quality of life among pediatric and adult patients with atopic dermatitis, according to interim results presented at the European Academy of Dermatology and Venerology Congress.

Deucrictibant was well tolerated in daily 40 mg doses and showed no new safety signals among patients with hereditary angioedema, according to a poster presented at Bradykinin Symposium 2024 in Berlin.

The U.S. Environmental Protection Agency awarded the New York State Department of Health $5 million to address indoor air quality issues and greenhouse gas reduction in schools.

BOSTON — The impact of e-cigarette use on eosinophil and basophil counts may depend on HIV serostatus, according to a study presented at the CHEST Annual Meeting.

Healio has announced the 2024 honorees of its peer-to-peer recognition program, Healio Honors.

ORLANDO — Breastfeeding during hospitalization right after birth was associated with a diminished rate of childhood asthma, according to an abstract presented during the American Academy of Pediatrics 2024 National Conference & Exhibition.

Orismilast outperformed placebo in the treatment of moderate to severe atopic dermatitis in adults, according to a poster presented at the European Academy of Dermatology and Venereology Congress.

Patients with wheat allergy dependent on augmentation factors, also known as WALDA, often may be sensitized to spelt and barley as well, according to a study published in Annals of Allergy, Asthma & Immunology.

Selling a medical practice is a complex transaction that involves not only the assets of the practice itself but also implicates associated real estate.

Congressman Mark DeSaulnier (CA-10) introduced H.R. 9550, or the “Protecting Children with Food Allergies Act,” to help make children with allergies safer in their schools.